Indications and uses
prevents and treats nausea, vomiting or dizziness associated with motion sickness
prevents and treats nausea, vomiting or dizziness associated with motion sickness
dosage should be taken 1 hour before travel starts Adults and children 12 years and over take 2 or 4 caplets once daily or as directed by doctor
Tamper Evident: do not use if safety seal under cap is broken or missing each caplet contains: calcium 28 mg store at 20°-25°C (68°-77°F), excursions permitted between 15-30°C(59-86°F)
Meclizine HCl 12.5mg
Antiemetic
prevents and treats nausea, vomiting or dizziness associated with motion sickness
Do not use for children under 12 years of age unless directed by a doctor.
Do not take this product, Unless directed by a doctor, if you have
Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (800-222-1222).
| Adults and children 12 years and over | take 2 or 4 caplets once daily or as directed by doctor |
Croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
(866) 562-2756 (Mon-Fri, 8 AM to 4 PM EST).
PHARBEST
NDC 16103-386-08
Manufactured in the USA
Motion Sickness Relief
MECLIZINE
Meclizine HCl 12.5 mg
Anti-Emetic
• Motion Sickness • Nausea • Vomiting
100 CAPLETS
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 16103-386-08 | 2024-12-31 | C162847 | 48780-1 | d6a99b39-35a2-a426-e053-dadaa90af4c2 | Drug Facts |
| 16103-386-11 | 2024-12-31 | C162847 | 48780-1 | d6a99b39-35a2-a426-e053-dadaa90af4c2 | Drug Facts |
| 16103-386-08 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-35a2-a426-e053-dadaa90af4c2 | Drug Facts |
| 16103-386-11 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-35a2-a426-e053-dadaa90af4c2 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16103-386-08 | MECLIZINE | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 3 | |
| 16103-386-11 | MECLIZINE | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16103-386-08 | EA - Each | 16103-386 | 2154668d-662d-47cf-bbf1-5bb5c63c750d | 1 | 2019-04-11 |
| 16103-386-11 | EA - Each | 16103-386 | 51f253cb-57da-41ee-bc3e-9f303e042a0e | 1 | 2019-04-11 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 16103-386 | 16103-386-08, 16103-386-11 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | L11K75P92J | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MECLIZINE | MECLIZINE HCL 12.5 MG | Pharbest Pharmaceuticals, Inc. | 8b3c9283-b618-4d57-9f15-7cf73e8737f5 | 2025-12-24 | Warnings | 16103-386-08 16103-386-11 16103-386 16103038611 16103038608 d7d81436-c338-4988-bf9e-a721e0cb8f91 8b3c9283-b618-4d57-9f15-7cf73e8737f5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.